Health Care Supplies

Cuprina

Cuprina released FY2025 Semi-Annual earnings on December 9, 2025 (EST), actual revenue USD 17.59 K, actual EPS USD -0.0775

Cuprina released FY2025 Q2 earnings on December 9 (EST), actual revenue USD 9.016 K, actual EPS USD -0.0397

Cuprina released FY2025 Q1 earnings on December 9, 2025 (EST), actual revenue USD 8.578 K, actual EPS USD -0.0377

Cuprina Holdings Conducts Collagen Peptide Clinical Study

Cuprina MENA Completes Lab in Saudi Arabia and Secures Exclusive Sales Rights

Cuprina released FY2024 Q3 earnings on May 14 (EST), actual revenue USD 2.857 K, actual EPS USD -0.0185

Cuprina released FY2024 9 Months earnings on May 14 (EST), actual revenue USD 33.18 K, actual EPS USD -0.0475

Cuprina released FY2024 Q4 earnings on May 14, 2025 (EST) with actual revenue of USD 2.689 K and EPS of USD -0.0174

Cuprina released FY2024 Annual Earnings on May 14 EST, with actual revenue of USD 36.14 K and EPS of USD -0.0648

Cuprina Holdings and Ferti-Craft Complete IVF Media Production Facility Construction

CUPR.US released FY2023 semi-annual earnings on December 6, BJT, with actual revenue of USD 33.3 K and EPS of USD -0.0187

CUPR.US released FY2024 semi-annual earnings on December 6 (BJT), with actual revenue of USD 30.32 K and EPS of USD -0.0289

Cuprina released FY2024 Q2 earnings on December 6, 2024 (EST), with actual revenue of USD 15.12 K and EPS of USD -0.0144

Cuprina Holdings (Cayman) Limited released FY2024 Q1 earnings on December 6, 2024 (EST), with actual revenue of USD 15.2 K and EPS of USD -0.0144

CUPR.US released FY2023 Q1 earnings on December 6, 2024 (BJT) with actual revenue of USD 16.8K and EPS of USD -0.0094

Cuprina Holdings (Cayman) Limited released FY2023 Q2 earnings on December 6, 2024 (EST), with actual revenue of USD 16.48 K and EPS of USD -0.0092

CUPR.US released FY2021 Annual Earnings on May 16 (BJT) with actual revenue of USD 43.34 K and EPS of USD -0.0213

Cuprina Holdings (Cayman) Limited released FY2023 9 Months Earnings on May 16, 2024 (EST), with actual revenue of USD 53.85 K and EPS of USD -0.0323

CUPR.US released FY2023 Q4 earnings on May 16 (BJT), actual revenue USD 21.25 K, actual EPS USD -0.014

CUPR.US released FY2022 Q3 earnings on May 16 (BJT), with actual revenue of USD 9.992 K and EPS of USD -0.0106

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Essilor

HOYA Corporation

Merit Medical

UFP Tech

Acme Utd

Xtant Med

STANDARD DENTAL LABS INC

Alcon

Cooper Cos

Solventum

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap